2019
DOI: 10.1101/620971
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A new approach to automated CBMN scoring following high doses

Abstract: In recent years we have automated the CBMN assay using microvolumes of blood, processed in multiwell plates. We have seen that at doses above 6 Gy the detected yield of micronuclei actually declines with dose, likely because of mitotic delay, preventing cells from forming micronuclei and also, when using one color imaging, resulting in many false binucleated cells, consisting of two randomly-adjacent nuclei. By using the inverse mitotic index (the ratio of mononuclear to binuclear cells) to adjust the micronuc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…A secondary staining to identify the boundaries of each cell can also be performed, although this step is often omitted, likely because it significantly reduces throughput. More commonly, MN associated with the nucleus are predicted using the proximity method [20].…”
Section: Cbmn Assaymentioning
confidence: 99%
See 1 more Smart Citation
“…A secondary staining to identify the boundaries of each cell can also be performed, although this step is often omitted, likely because it significantly reduces throughput. More commonly, MN associated with the nucleus are predicted using the proximity method [20].…”
Section: Cbmn Assaymentioning
confidence: 99%
“…A research group from the Center for High-Throughput Minimally Invasive Radiation Biodosimetry at Columbia University has developed a robotic platform called Robotic Automated Biodosimetry Technology (RABiT) for the highthroughput processing of cytogenetic biodosimetry techniques, such as the CBMN assay and DCA [19,20]. In several of their recent publications, this group has described the development of RABiT-II, with the aim to implement standard cytogenetic assays in a 96-well plate format and analyzing them using commercial, automated, high-throughput screening platforms.…”
Section: Cbmn Assaymentioning
confidence: 99%